Advanced search
Publication Cover
Cancer Biology & Therapy Volume 13, 2012 - Issue 9
Submit an article Journal homepage
966
Views
47
CrossRef citations to date
0
Altmetric
Research Paper

Selenium-containing histone deacetylase inhibitors for melanoma management

Raghavendra Gowda Department of Pharmacology; Pennsylvania State University College of Medicine; Hershey, PA USA; Penn State Melanoma Center; Pennsylvania State University College of Medicine; Hershey, PA USA; Penn State Melanoma Therapeutics Program; Pennsylvania State University College of Medicine; Hershey, PA USA
,
SubbaRao V. Madhunapantula Department of Pharmacology; Pennsylvania State University College of Medicine; Hershey, PA USA; Penn State Melanoma Center; Pennsylvania State University College of Medicine; Hershey, PA USA; Penn State Melanoma Therapeutics Program; Pennsylvania State University College of Medicine; Hershey, PA USA
,
Dhimant Desai Department of Pharmacology; Pennsylvania State University College of Medicine; Hershey, PA USA
,
Shantu Amin Department of Pharmacology; Pennsylvania State University College of Medicine; Hershey, PA USA
&
Gavin P. Robertson Department of Pharmacology; Pennsylvania State University College of Medicine; Hershey, PA USA; Department of Pathology; Pennsylvania State University College of Medicine; Hershey, PA USA; Deparment of Dermatology; Pennsylvania State University College of Medicine; Hershey, PA USA; Department of Surgery; Pennsylvania State University College of Medicine; Hershey, PA USA; Penn State Melanoma Center; Pennsylvania State University College of Medicine; Hershey, PA USA; The Foreman Foundation for Melanoma Research; Pennsylvania State University College of Medicine; Hershey, PA USA; Penn State Melanoma Therapeutics Program; Pennsylvania State University College of Medicine; Hershey, PA USACorrespondence[email protected]
Pages 756-765 | Received 30 Jan 2012, Accepted 29 Apr 2012, Published online: 06 Jun 2012

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

SubbaRao V. Madhunapantula & Gavin P. Robertson. (2017) Targeting protein kinase-b3 (akt3) signaling in melanoma. Expert Opinion on Therapeutic Targets 21:3, pages 273-290.
Read now
Bodo Speckmann & Tilman Grune. (2015) Epigenetic effects of selenium and their implications for health. Epigenetics 10:3, pages 179-190.
Read now

Articles from other publishers (45)

Rui Lei, Xiao Liu & Jinfeng Wu. (2023) Nutrition and melanoma: the contribution of trace elements in onset, progression, and treatment of melanoma. Nutrition Reviews.
Crossref
Mikhail V. Andreev, Vladimir A. Potapov, Maxim V. Musalov & Lyudmila I. Larina. (2023) A New Family of Vinyl Selenocyanates with the Amide Function Based on the Reaction of Potassium Selenocyanate with 3-Trimethylsilyl-2-Propynamides. Catalysts 13:9, pages 1257.
Crossref
Silke Geurs, Dorien Clarisse, Karolien De Bosscher & Matthias D’hooghe. (2023) The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs. Journal of Medicinal Chemistry 66:12, pages 7698-7729.
Crossref
Sashi Debnath, Abhijeet Agarwal, Neha R. Kumar & Anjan Bedi. (2022) Selenium-Based Drug Development for Antioxidant and Anticancer Activity. Future Pharmacology 2:4, pages 595-607.
Crossref
I. Anestopoulos, S. Kyriakou, V. Tragkola, I. Paraskevaidis, E. Tzika, M. Mitsiogianni, M.V. Deligiorgi, G. Petrakis, D.T. Trafalis, S. Botaitis, A. Giatromanolaki, M.I. Koukourakis, R. Franco, A. Pappa & M.I. Panayiotidis. (2022) Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises. Pharmacology & Therapeutics 240, pages 108301.
Crossref
Yue Zhang & Qing He. (2022) The role of SELENBP1 and its epigenetic regulation in carcinogenic progression. Frontiers in Genetics 13.
Crossref
Yitong Zhao, Yuanxu Guo, Mengyao Sun, Safdar Hussion, Ying Zheng, Huang Huang, Xinyu Huo, Yutong Zhao, Fujun Zhang, Yan Han, Qilan Ning, Peng Xu, Jian Sun & Shemin Lu. (2022) Selenium-sensitive histone deacetylase 2 is required for forkhead box O3A and regulates extracellular matrix metabolism in cartilage. Journal of Bone and Mineral Metabolism 40:6, pages 914-926.
Crossref
Mahadevaswamy G. Kuruburu, Venugopal R. Bovilla, Zonunsiami Leihang & SubbaRao V. Madhunapantula. (2022) Phytochemical-rich Fractions from Foxtail Millet (Setaria italica (L.) P. Beauv) Seeds Exhibited Antioxidant Activity and Reduced the Viability of Breast Cancer Cells In Vitro by Inducing DNA Fragmentation and Promoting Cell Cycle Arrest. Anti-Cancer Agents in Medicinal Chemistry 22:13, pages 2477-2493.
Crossref
Dusan Ruzic, Nemanja Djoković, Tatjana Srdić-Rajić, Cesar Echeverria, Katarina Nikolic & Juan F. Santibanez. (2022) Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention. Pharmaceutics 14:1, pages 209.
Crossref
Theolan Adimulam, Thilona Arumugam, Ashmika Foolchand, Terisha Ghazi & Anil A. Chuturgoon. (2021) The Effect of Organoselenium Compounds on Histone Deacetylase Inhibition and Their Potential for Cancer Therapy. International Journal of Molecular Sciences 22:23, pages 12952.
Crossref
Hongyan Chuai, San-Qi Zhang, Huanrong Bai, Jiyu Li, Yang Wang, Jiajia Sun, Ergang Wen, Jiye Zhang & Minhang Xin. (2021) Small molecule selenium-containing compounds: Recent development and therapeutic applications. European Journal of Medicinal Chemistry 223, pages 113621.
Crossref
Eduard Yakubov, Thomas Eibl, Alexander Hammer, Markus Holtmannspötter, Nicolai Savaskan & Hans-Herbert Steiner. (2021) Therapeutic Potential of Selenium in Glioblastoma. Frontiers in Neuroscience 15.
Crossref
Orjon Rroji, Amit Kumar, Saravanan S. Karuppagounder & Rajiv R. Ratan. (2021) Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases. Neurobiology of Disease 147, pages 105145.
Crossref
Anait S. Levenson. 2021. Medical Epigenetics. Medical Epigenetics 741 816 .
Antoni Sureda, Xavier Capó & Silvia Tejada. 2021. Nutraceuticals and Cancer Signaling. Nutraceuticals and Cancer Signaling 545 568 .
Paloma Begines, Lucía Sevilla-Horrillo, Adrián Puerta, Rebecca Puckett, Samuel Bayort, Irene Lagunes, Inés Maya, José M. Padrón, Óscar López & José G. Fernández-Bolaños. (2020) Masked Phenolic-Selenium Conjugates: Potent and Selective Antiproliferative Agents Overcoming P-gp Resistance. Pharmaceuticals 13:11, pages 358.
Crossref
Viola Previtali, Goar Sánchez‐Sanz & Cristina Trujillo. (2019) Theoretical Investigation of Cyano‐Chalcogen Dimers and Their Importance in Molecular Recognition. ChemPhysChem 20:23, pages 3186-3194.
Crossref
Ho-Sun Lee. 2019. Nutritional Epigenomics. Nutritional Epigenomics 153 166 .
Wesam Ali, Mónica Álvarez-Pérez, Małgorzata Anna Marć, Noemi Salardón-Jiménez, Jadwiga Handzlik & Enrique Domínguez-Álvarez. (2018) The Anticancer and Chemopreventive Activity of Selenocyanate-Containing Compounds. Current Pharmacology Reports 4:6, pages 468-481.
Crossref
Jolyn Fernandes, Xin Hu, M. Ryan Smith, Young-Mi Go & Dean P. Jones. (2018) Selenium at the redox interface of the genome, metabolome and exposome. Free Radical Biology and Medicine 127, pages 215-227.
Crossref
Valentina Gandin, Prajakta Khalkar, Jeremy Braude & Aristi P. Fernandes. (2018) Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment. Free Radical Biology and Medicine 127, pages 80-97.
Crossref
Rachana Garg, Jorge M. Blando, Carlos J. Perez, Priti Lal, Michael D. Feldman, Emer M. Smyth, Emanuela Ricciotti, Tilo Grosser, Fernando Benavides & Marcelo G. Kazanietz. (2018) COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer. Oncogene 37:34, pages 4735-4749.
Crossref
D. Cheshmedzhieva, N. Toshev, M. Gerova, O. Petrov & T. Dudev. (2018) Hydroxamic acid derivatives as histone deacetylase inhibitors: a DFT study of their tautomerism and metal affinities/selectivities. Journal of Molecular Modeling 24:5.
Crossref
Raghavendra Gowda, Saketh S. Dinavahi, Soumya Iyer, Shubhadeep Banerjee, Rogerio I. Neves, Colette R. Pameijer & Gavin P. Robertson. (2018) Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment. Nanomedicine: Nanotechnology, Biology and Medicine 14:3, pages 863-873.
Crossref
Asha Jose, Motamari V. N. L. Chaitanya, Elango Kannan & SubbaRao V. Madhunapantula. (2018) Tricaproin Isolated From Simarouba glauca Inhibits the Growth of Human Colorectal Carcinoma Cell Lines by Targeting Class-1 Histone Deacetylases. Frontiers in Pharmacology 9.
Crossref
Mónica Álvarez-Pérez, Wesam Ali, Małgorzata Marć, Jadwiga Handzlik & Enrique Domínguez-Álvarez. (2018) Selenides and Diselenides: A Review of Their Anticancer and Chemopreventive Activity. Molecules 23:3, pages 628.
Crossref
Prajakta Khalkar, Hani Abdulkadir Ali, Paula Codó, Nuria Díaz Argelich, Anni Martikainen, Mohsen Karimi Arzenani, Sören Lehmann, Julian Walfridsson, Johanna Ungerstedt & Aristi P. Fernandes. (2018) Selenite and methylseleninic acid epigenetically affects distinct gene sets in myeloid leukemia: A genome wide epigenetic analysis. Free Radical Biology and Medicine 117, pages 247-257.
Crossref
Bozena Hosnedlova, Marta Kepinska, Sylvie Skalickova, Carlos Fernandez, Branislav Ruttkay-Nedecky, Thembinkosi Donald Malevu, Jiri Sochor, Mojmir Baron, Magdalena Melcova, Jarmila Zidkova & Rene Kizek. (2017) A Summary of New Findings on the Biological Effects of Selenium in Selected Animal Species—A Critical Review. International Journal of Molecular Sciences 18:10, pages 2209.
Crossref
Omer F. Kuzu, Raghavendra Gowda, Arati Sharma, Mohammad A. Noory, Saketh S. Dinavahi, Gregory Kardos, Joseph J. Drabick & Gavin P. Robertson. (2017) Improving pharmacological targeting of AKT in melanoma. Cancer Letters 404, pages 29-36.
Crossref
Raghavendra Gowda, Gajanan S. Inamdar, Omer Kuzu, Saketh S. Dinavahi, Jacek Krzeminski, Madhu Babu Battu, Sreedhara R. Voleti, Shantu Amin & Gavin P. Robertson. (2017) Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport. Oncotarget 8:17, pages 28260-28277.
Crossref
Raghavendra Gowda, Gregory Kardos, Arati Sharma, Sanjay Singh & Gavin P. Robertson. (2017) Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma. Molecular Cancer Therapeutics 16:3, pages 440-452.
Crossref
María Díaz-Núñez, Alejandro Díez-Torre, Olivier De Wever, Ricardo Andrade, Jon Arluzea, Margarita Silió & Juan Aréchaga. (2016) Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity. BMC Cancer 16:1.
Crossref
Eva Hornig, Markus V. Heppt, Saskia A. Graf, Thomas Ruzicka & Carola Berking. (2016) Inhibition of histone deacetylases in melanoma-a perspective from bench to bedside. Experimental Dermatology 25:11, pages 831-838.
Crossref
A. Kumar, N.A. Butt & A.S. Levenson. 2016. Medical Epigenetics. Medical Epigenetics 747 798 .
Andrew C. Kotze, Barney M. Hines, Neil H. Bagnall, Clare A. Anstead, Praveer Gupta, Robert C. Reid, Angela P. Ruffell & David P. Fairlie. (2015) Histone deacetylase enzymes as drug targets for the control of the sheep blowfly, Lucilia cuprina. International Journal for Parasitology: Drugs and Drug Resistance 5:3, pages 201-208.
Crossref
Beatriz Romano, Daniel Plano, Ignacio Encío, Juan Antonio Palop & Carmen Sanmartín. (2015) In vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates. Bioorganic & Medicinal Chemistry 23:8, pages 1716-1727.
Crossref
Holger Schipper, Vijay Alla, Claudia Meier, Dirk M. Nettelbeck, Ottmar Herchenröder & Brigitte M. Pützer. (2014) Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus. Oncotarget 5:15, pages 5893-5907.
Crossref
Beatriz Romano, María Font, Ignacio Encío, Juan Antonio Palop & Carmen Sanmartín. (2014) Synthesis and antiproliferative activity of novel methylselenocarbamates. European Journal of Medicinal Chemistry 83, pages 674-684.
Crossref
Omer F. Kuzu, Raghavendra Gowda, Arati Sharma & Gavin P. Robertson. (2014) Leelamine Mediates Cancer Cell Death through Inhibition of Intracellular Cholesterol Transport. Molecular Cancer Therapeutics 13:7, pages 1690-1703.
Crossref
Raghavendra Gowda, SubbaRao V. Madhunapantula, Omer F. Kuzu, Arati Sharma & Gavin P. Robertson. (2014) Targeting Multiple Key Signaling Pathways in Melanoma Using Leelamine. Molecular Cancer Therapeutics 13:7, pages 1679-1689.
Crossref
Jie Liu, Jia Li, Jian-Fang Zhang & Xiao-Yan Xin. (2013) Combination of Fenretinide and Selenite Inhibits Proliferation and Induces Apoptosis in Ovarian Cancer Cells. International Journal of Molecular Sciences 14:11, pages 21790-21804.
Crossref
I. Venza, M. Visalli, R. Oteri, M. Cucinotta, D. Teti & M. Venza. (2013) Class II ‐specific histone deacetylase inhibitors MC 1568 and MC 1575 suppress IL ‐8 expression in human melanoma cells . Pigment Cell & Melanoma Research 26:2, pages 193-204.
Crossref
Arun K SharmaShantu Amin. (2013) Post SELECT: selenium on trial. Future Medicinal Chemistry 5:2, pages 163-174.
Crossref
Raghavendra Gowda, SubbaRao V. Madhunapantula, Dhimant Desai, Shantu Amin & Gavin P. Robertson. (2013) Simultaneous Targeting of COX-2 and AKT Using Selenocoxib-1-GSH to Inhibit Melanoma. Molecular Cancer Therapeutics 12:1, pages 3-15.
Crossref
Ioannis Anestopoulos, Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Eleni Tzika, Melina Mitsiogianni, Maria Deligiorgi, Giorgos Petrakis, Dimitrios T. Trafalis, Sotiris Botaitis, Alexandra Giatromanolaki, Michail I. Koukourakis, Franco Rodrigo, Aglaia Pappa & Mihalis Panagiotidis. (2022) Targeting the Epigenome in Malignant Melanoma: Facts, Challenges and Therapeutic Promises. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.